Mechanisms involved in the bidirectional effects of protein kinase C activators on neutrophil responses to leukotriene B4
- PMID: 2155269
Mechanisms involved in the bidirectional effects of protein kinase C activators on neutrophil responses to leukotriene B4
Abstract
Three protein kinase C (PKC) activators (PMA, mezerein, and a diacylglycerol) had bidirectional effects on human polymorphonuclear neutrophil (PMN) degranulation responses to leukotriene (LT) B4. Lower concentrations of the three agents enhanced, whereas higher concentrations inhibited, release of lysozyme and beta-glucuronidase stimulated by the arachidonic acid metabolite. Contrastingly, the activators inhibited but never enhanced LTB4-induced Ca2+ transients. We examined the causes for these varying effects. Each PKC activator reduced PMN specific binding of [3H]LTB4. Scatchard analyses revealed that PMA (greater than or equal to 0.16 nM) decreased the number of high affinity LTB4 receptors. The receptor losses correlated closely with inhibition of Ca2+ transients. PMN pretreated with 0.5 nM PMA for 5 min retained approximately 50% of their high affinity LTB4 receptors. These cells responded to 10 nM LTB4 with reduced but still substantial rises in cytosolic Ca2+, enhanced PKC mobilization, and increased granule enzyme release. The latter two effects appeared calcium-dependent because sequential exposure to PMA and LTB4 did not synergistically stimulate PKC mobilization or degranulation in PMN that were: 1) Ca2(+)-depleted; 2) challenged with 5 nM PMA; or 3) treated with LTB4 for 5 min before PMA. Each of the latter treatments completely interfered with the extent or timing of LTB4-induced Ca2+ transients. Accordingly, we suggest that the response-specific, bidirectional effects of PKC activators on LTB4 result from two opposing mechanisms. First, PKC activators down-regulate LTB4 high affinity receptors and thereby reduce those PMN responses that are not elicited by activated PKC (i.e., Ca2+ transients). Second, LTB4, by elevating cytosolic Ca2+, increases the amount of PKC mobilized by PKC activators and thereby promotes PKC-dependent responses (e.g., degranulation). The two mechanisms may be pertinent to the bidirectional effects of PKC activators on various other agonists. Furthermore, PKC, by down-regulating receptors, may serve as a physiologic stop signal for terminating function and producing a poststimulatory state of desensitization.
Similar articles
-
Arachidonate metabolites, platelet-activating factor, and the mobilization of protein kinase C in human polymorphonuclear neutrophils.J Immunol. 1987 Mar 15;138(6):1889-95. J Immunol. 1987. PMID: 3029224
-
Phorbol myristate acetate and the calcium ionophore A23187 synergistically induce release of LTB4 by human neutrophils: involvement of protein kinase C activation in regulation of the 5-lipoxygenase pathway.J Immunol. 1987 May 15;138(10):3396-402. J Immunol. 1987. PMID: 3033073
-
Dual effect of phorbol myristate acetate on chemoattractant-induced locomotion of human neutrophils.Nouv Rev Fr Hematol (1978). 1990;32(3):191-8. Nouv Rev Fr Hematol (1978). 1990. PMID: 2170935
-
Regulation of the receptor system for leukotriene B4 on human neutrophils.Ann N Y Acad Sci. 1988;524:187-95. doi: 10.1111/j.1749-6632.1988.tb38541.x. Ann N Y Acad Sci. 1988. PMID: 2837954 Review. No abstract available.
-
Receptors and intracellular signaling in human neutrophils.Am Rev Respir Dis. 1990 Mar;141(3 Pt 2):S127-31. doi: 10.1164/ajrccm/141.3_Pt_2.S127. Am Rev Respir Dis. 1990. PMID: 2178532 Review.
Cited by
-
Role of leukotrienes in antimicrobial host defense of the lung.Clin Rev Allergy Immunol. 1999 Spring-Summer;17(1-2):261-9. doi: 10.1007/BF02737609. Clin Rev Allergy Immunol. 1999. PMID: 10436871 Review. No abstract available.
-
Optimization and technological development strategies of an antimicrobial extract from Achyrocline alata assisted by statistical design.PLoS One. 2015 Feb 24;10(2):e0118574. doi: 10.1371/journal.pone.0118574. eCollection 2015. PLoS One. 2015. PMID: 25710523 Free PMC article.
-
PAF. A review of its effects, antagonists and possible future clinical implications (Part II).Drugs. 1991 Aug;42(2):174-204. doi: 10.2165/00003495-199142020-00002. Drugs. 1991. PMID: 1717219 Review. No abstract available.
-
Eicosapentaenoic acid modulates neutrophil leukotriene B4 receptor expression in cystic fibrosis.Clin Exp Immunol. 1994 Oct;98(1):12-6. doi: 10.1111/j.1365-2249.1994.tb06599.x. Clin Exp Immunol. 1994. PMID: 7923869 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Miscellaneous